Evaluation of the Clinical Utility of an AChRAb ELISA Kit

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030260189

Enrollment

Registered

2026-06-03

Start date

2026-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 18 years or older who were previously diagnosed with myasthenia gravis (MG) at a medical institution and who provided informed consent to participate in this study. The diagnosis of myasthenia gravis (MG) shall be made in accordance with the 2022 Diagnostic Criteria for Myasthenia Gravis.

Exclusion criteria

Exclusion criteria: Individuals who are deemed unsuitable for participation in this study by the principal investigator or sub-investigators.

Design outcomes

Primary

Measure	Time frame
Agreement rate between the new kit and AChRAb Cosmic II RIA method and AChRAb ELISA Euroimmun	—

Contacts

Public ContactTanaka Megumi

Cosmic Corporation

ph3@cosmic-jpn.co.jp+81-358029321

Outcome results